none title certification

Optimapharm Lithuania UAB Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data
Financial report background

Financial statement report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
819,964
53,592
31,572
25,841
1,689
15.42
3.15
204,738
72,010
0
276,705
2022
743,587
50,208
28,459
23,508
1,587
13.48
3.16
228,246
101,685
0
329,722
2023
1,020,985
69,172
56,423
36,814
2,494
15.25
3.61
265,060
264,334
706
507,249
unlock data icon

Register and

explore Okredo data
2023
1,020,985
69,172
56,423
36,814
2,494
15.25
3.61
265,060
264,334
706
507,249
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

1,020,985 €Ascended37 % *

Sales per employee (€)

69,172 €Ascended38 % *

Profit before tax (€)

56,423 €Ascended98 % *

Net Profit (€)

36,814 €Ascended57 % *

Profit per employee (€)

2,494 €Ascended57 % *

Total profitability (%)

15.25 %Ascended13.13 % *

Net profitability (%)

3.61 %Ascended14.24 % *

Equity (€)

265,060 €Ascended16 % *

Amounts Payable And Liabilities (€)

264,334 €Ascended160 % *

Non-current Assets (€)

706 €Ascended- *

CurrentAssets (€)

507,249 €Ascended54 % *

*over the last year starting selected period